Focal Therapy and Interventional Urology
Our interventional urology program, led by Ardeshir R. Rastinehad, DO, uses a team approach and incorporate the latest imaging technological advances and equipment. Our interventional urology team includes interventional radiologists Aaron Fischman, MD, and Gajan Sivananthan, MD. Our team approach helps us develop new therapies and move them as efficiently as possible from the research bench to clinical practice.
Interventional urology provides care for many urologic conditions in the most minimally invasive fashion possible. New approaches include state-of-the-art prostate cancer screening technologies, focal therapies for prostate cancer, minimally invasive kidney cancer treatments, embolization for benign prostate hyperplasia (BPH), and non-surgical approaches to treat varicoceles and erectile dysfunction.
Dr. Rastinehad is the world’s first dual fellowship-trained urologic oncologist and interventional radiologist. His oncology research focuses on image optimization for prostate cancer screening and treatment. He developed the first electromagnetically tracked magnetic resonance ultrasound fusion biopsy platform to perform transperineal biopsies. This method offers a lower morbidity rate than the standard approach. Using the image-based biopsy platform (the first U.S. Food and Drug Administration-cleared device for guidance for focal therapy), he performed the world’s first gold nano-particle directed laser ablation for prostate cancer. Dr. Rastinehad continues to perform advanced research, collaborating with investigators from the National Institutes of Health, Case Western Reserve University, and the Smith Institute for Urology.
Dr. Rastinehad continues to develop therapies for benign urologic diseases as well. He has extensive experience in performing prostate artery embolizations for the treatment of BPH. Almost all urologic treatments of BPH have negative sexual side effects and affect quality of life, but prostate artery embolization does not have any of these. Generally, patients report improvement in their erections.
Mount Sinai Firsts
At Mount Sinai, we have made—and continue to make—groundbreaking contributions to the field of urology. Here are some of our “firsts”:
- First textbook on interventional urology
- First magnetic resonance imaging/ultrasound fusion-guided tansperineal biopsy using electromagnetic tracking
- World’s first magnetic resonance imaging/ultrasound fusion-guided gold nanoparticle-directed laser ablation of prostate cancer
- First dual fellowship-trained urologic oncologist and interventional radiologist
- First in the world magnetic resonance imaging/ultrasound fusion-guided prostate biopsy course, in collaboration with the American Urological Association